Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- AIDS (1)
- Access to essential medicine (1)
- Biodefense strategy (1)
- COVID-19 (1)
- Climate change (1)
-
- Climate mitigation (1)
- Collective action problem (1)
- Cooperative federalism (1)
- Developing countries (1)
- Disaster response (1)
- Extreme weather events (1)
- HIV (1)
- Inequity (1)
- Intellectual Property (1)
- Military operations (1)
- Patents (1)
- Pharmaceutical companies (1)
- Security threats (1)
- TRIPs Agreement (1)
- U.N. Security Council (1)
- United States (1)
- Voluntary drug price reductions (1)
- WTO (1)
- World Health Organization (1)
Articles 1 - 2 of 2
Full-Text Articles in Health Law and Policy
Climate Security Insights From The Covid-19 Response, Mark P. Nevitt
Climate Security Insights From The Covid-19 Response, Mark P. Nevitt
Faculty Articles
The climate change crisis and COVID-19 crisis are both complex collective action problems. Neither the coronavirus nor greenhouse gas (GHG) emissions respect political borders. Both impose an opportunity cost that penalizes inaction. They are also increasingly understood as nontraditional, novel security threats. Indeed, COVID-19’s human cost is staggering, with American lives lost vastly exceeding those lost in recent armed conflicts. And climate change is both a threat accelerant and a catalyst for conflict—a characterization reinforced in several climate-security reports. To counter COVID-19, the President embraced martial language, stating that he will employ a “wartime footing” to “defeat the virus.” Perhaps …
Legal Movements In Intellectual Property: Trips, Unilateral Action, Bilateral Agreements, And Hiv/Aids, Margo A. Bagley
Legal Movements In Intellectual Property: Trips, Unilateral Action, Bilateral Agreements, And Hiv/Aids, Margo A. Bagley
Faculty Articles
This Article begins with an overview of the relationship between the Agreement on Trade-Related Aspects of Intellectual Property Rights (the "TRIPS Agreement") and the HIV/AIDS pandemic which created the need for the Doha Declaration. It then discusses two trade-related movements, unilateral action and TRIPS-plus bilateral agreements, that call into question the long-term effectiveness of the TRIPS Agreement process, generally, and the benefits of the Doha Declaration, in particular, in addressing multiple facets of the access to essential medicines problem. This Article concludes that a consideration of these issues should be included in the development of any further TRIPS-related solutions to …